Contact this trialFirst, we need to learn more about you.
Hormone Therapy
Melatonin + Erythropoietin for Intraventricular Hemorrhage
Recruiting0 awardsPhase 1
Baltimore, Maryland
This trial is testing melatonin and erythropoietin in very premature babies with severe brain bleeding. The goal is to see if these substances can protect the brain and prevent a condition that currently requires surgery. If successful, this could reduce lifelong complications for these infants. Erythropoietin has been shown to have protective effects on the brain and is often used in premature infants.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service